Healthcare solution provider Twisted Ceptors Corporation has announced their MIMIC network can enable instantaneous, secure transmission of mobile ultrasound imaging and reports, making it easier for providers to share images with patients without requiring the patients to leave their homes.
“We believe this sets us apart from other vendors in this marketplace,” said Michael A. Muscato, Twisted Ceptors founder. “To provide a totally free service that continues to support our mandate of improving patient care through cooperative sharing is a game changer.”
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
By using its MDRIVE “edge” technology, MIMIC has developed what amounts to a mobile radiology office that can immediately send studies and reports to the company’s vendor neutral archive. This functionality requires no USB storage sticks or bulk data transfers, and it prevents incomplete study uploads.
The social network shares image instantly via low-cost communication devices that have financial-grade security and encryption. In addition, 5G-capable network connectivity, as well as the MIMIC cloud, make it possible for mobile imaging technologists to send studies to the physician while still present with the patient.
Social Radiology Network Enables Instant Mobile Ultrasound Imaging Anywhere
Functionality improves patient care by allowing secure image share with providers before technologists leave patients.
Healthcare solution provider Twisted Ceptors Corporation has announced their MIMIC network can enable instantaneous, secure transmission of mobile ultrasound imaging and reports, making it easier for providers to share images with patients without requiring the patients to leave their homes.
“We believe this sets us apart from other vendors in this marketplace,” said Michael A. Muscato, Twisted Ceptors founder. “To provide a totally free service that continues to support our mandate of improving patient care through cooperative sharing is a game changer.”
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
By using its MDRIVE “edge” technology, MIMIC has developed what amounts to a mobile radiology office that can immediately send studies and reports to the company’s vendor neutral archive. This functionality requires no USB storage sticks or bulk data transfers, and it prevents incomplete study uploads.
The social network shares image instantly via low-cost communication devices that have financial-grade security and encryption. In addition, 5G-capable network connectivity, as well as the MIMIC cloud, make it possible for mobile imaging technologists to send studies to the physician while still present with the patient.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Information-Blocking and Interoperability Compliance
April 29th 2021Matthew Michela, President and CEO of Life Image, discusses ONC information-blocking rules and strategies practices can take to ensure compliance.
FDA Clears Updated Version of Sonio Detect Fetal Ultrasound Device
May 15th 2024The second version of the device reportedly detects T2/T3 fetal ultrasound views with 93.7 percent sensitivity and enables 63 percent of AIUM exam protocols without manual annotation.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Information-Blocking and Interoperability Compliance
April 29th 2021Matthew Michela, President and CEO of Life Image, discusses ONC information-blocking rules and strategies practices can take to ensure compliance.
FDA Clears Updated Version of Sonio Detect Fetal Ultrasound Device
May 15th 2024The second version of the device reportedly detects T2/T3 fetal ultrasound views with 93.7 percent sensitivity and enables 63 percent of AIUM exam protocols without manual annotation.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.